4
0
A. Teimouri et al. / Journal of Molecular Catalysis A: Chemical 373 (2013) 38–45
+
◦ −1
Compound 2f: Mp 126–128 C. FTIR (KBr, cm ): 3440, 1646,
1461 cm ; H NMR (400 MHz, DMSO-d6): ı 2.31 (s, 3H), 7.26–7.37
(
2C), 152.9; ESI MS (m/z): 194.08 (M ); Anal. Calcd. for C13H10N :
2
−
1 1
C, 80.39; H, 5.19; N, 14.42. Found: C, 80.11; H, 4.89; N, 14.10.
Compound 1b: Mp 290–292 C. FTIR (KBr, cm ): 3446, 1628,
477 cm ; H NMR (400 MHz, DMSO-d6): ı 7.28 (d, 2H), 7.30–7.34
◦
−1
(d, 2H), 7.41–7.49 (m, 1H), 7.56–7.65 (d, 2H), 7.24–7. 74 (m, 1H),
−1
1
13
1
8.06–8.22 (m, 2H); C NMR (400 MHz, DMSO-d6): ı 21.3, 110.7,
(
m, 2H), 7.38–7.42 (m, 1H), 7.62–7.66 (m, 1H), 8.56 (d, 2H), 12.13
119.6, 123.4, 124.8, 126.4, 127.4 (2C), 129.6 (2C), 138.4, 141.5, 150.4,
162.2; ESI MS (m/z): 209.08 (M ); Anal. Calcd for C14H11NO: C,
+
+
(
s, 1H); ESI MS (m/z): 228.05 (M ); Anal. Calcd for C13H ClN : C,
9
2
6
8.28; H, 3.97; N, 15.50. Found: C, 67.86; H, 3.59; N, 15.16.
80.36; H, 5.30; N, 6.69. Found: C, 79.98; H, 5.02; N, 6.32.
◦
−1
◦ −1
Compound 2g: Mp 96–98 C. FTIR (KBr, cm ): 3448, 1651,
Compound 1c: Mp 268–270 C. FTIR (KBr, cm ): 3438, 1635,
−1
1
−1
1
1
434 cm ; H NMR (400 MHz, DMSO-d6): ı 7.32 (d, 2H), 7.38–7.42
1462 cm ; H NMR (400 MHz, DMSO-d6): ı 3.64 (s, 3H), 7.28–7.39
(
m, 2H), 7.46–7.50 (m, 1H), 7.66–7.70 (m, 1H), 8.44 (d, 2H), 12.53
(d, 2H), 7.44–7.52 (m, 1H), 7.54–7.63 (d, 2H), 7.33–7.53 (m, 1H),
8.11–8.27 (m, 2H); C NMR (400 MHz, DMSO-d6): ı 54.3, 110.7,
+
13
(
s, 1H); ESI MS (m/z): 271.95 (M ); Anal. Calcd for C13H BrN : C,
9
2
5
7.18; H, 3.32; N, 29.26. Found: C, 56.89; H, 3.09; N, 28.87.
116.4 (2C), 118.5, 121.3, 122.4, 124.7, 127.6 (2C), 142.2, 150.4, 161.4,
◦
−1
+
Compound 1d: Mp 318–320 C. FTIR (KBr, cm ): 3448, 1626,
164.7;ESI MS (m/z): 225.08 (M ); Anal. Calcd for C14H11NO : C,
2
−1
1
1
587, 1529, 1356 cm
;
H NMR (400 MHz, DMSO-d6): ı 7.26 (d,
74.65; H, 4.92; N, 6.22. Found: C, 74.22; H, 4.62; N, 6.02.
◦ −1
Compound 3a: Mp 110–112 C. FTIR (KBr, cm ): 3426, 1658,
2
H), 7.34–7.38 (m, 2H), 7.42–7.48 (m, 1H), 7.58–7.63 (m, 1H), 8.62
+
−1
1
(
d, 2H), 12.28 (s, 1H); ESI MS (m/z): 239.08 (M ); Anal. Calcd for
1448 cm
; H NMR (400 MHz, DMSO-d6): ı 7.38–7.42 (m, 5H),
13
C13H N O : C, 65.27; H, 3.79; N, 17.56. Found: C, 65.06; H, 3.39; N,
7.66–7.73 (m, 4H); C NMR (400 MHz, DMSO-d6): ı 121.8, 122.2,
9
3
2
1
7.19.
123.5, 125.6 (2C), 126.6, 129.2 (2C), 132.3, 135.3, 151.1, 154.2,
◦
−1
+
Compound 1e: Mp 288–290 C. FTIR (KBr, cm ): 3561, 3434,
166.3;ESI MS (m/z): 211.05 (M ); Anal. Calcd for C13H NS: C, 73.90;
9
−1
1
1
7
2
621, 1463 cm
;
H NMR (400 MHz, DMSO-d6): ı 7.23 (d, 2H),
H, 4.59; N, 6.63. Found: C, 73.56; H, 3.86; N, 6.44.
◦ −1
Compound 3b: Mp 106–108 C. FTIR (KBr, cm ): 3456, 1638,
.29–7.33 (m, 2H), 7.38–7.42 (m, 1H), 7.64–7.68 (m, 1H), 8.44 (d,
+
−1
1
H), 9.58 (s, 1H), 12.32 (s, 1H); ESI MS (m/z): 210.07 (M ); Anal.
1445 cm
; H NMR (400 MHz, DMSO-d6): ı 7.24–7.35 (d, 2H),
Calcd for C13H10N O: C, 74.27; H, 4.79; N, 13.33. Found: C, 74.06;
7.48–7.56 (m, 1H), 7.62–7.71 (d, 2H), 7.40–7. 81 (m, 1H), 8.31–8.48
2
+
H, 4.38; N, 13.88.
(m, 2H); ESI MS (m/z): 245.01 (M ); Anal. Calcd for C13H ClNS: C,
8
◦
−1
Compound 1f: Mp 260–262 C. FTIR (KBr, cm ): 3432, 1622,
63.54; H, 3.28; N, 5.70. Found: C, 63.11; H, 2.94; N, 5.42.
−1
1
◦ −1
Compound 3c: Mp 102–104 C. FTIR (KBr, cm ): 3450, 1644,
1
456 cm
;
H NMR (400 MHz, DMSO-d6): ı 2.35 (s, 3H), 7.16 (d,
−
1
1
2
H), 7.32–7.38 (m, 2H), 7.43–7.49 (m, 1H), 7.61–7.64 (m, 1H), 8.09
1432 cm
; H NMR (400 MHz, DMSO-d6): ı 7.31–7.42 (d, 2H),
1
3
(
(
d, 2H), 12.80 (s, 1H); C NMR (400 MHz, DMSO-d6): ı 24.3, 115.3
2C), 123.0 (2C), 127.4 (2C), 127.7, 129.6 (2C), 137.4, 138.7 (2C),
7.50–7.58 (m, 1H), 7.64–7.73 (d, 2H), 7.48–7. 88 (m, 1H), 8.26–8.32
+
(m, 2H); ESI MS (m/z): 288.96 (M ); Anal. Calcd for C13H BrNS: C,
8
+
1
52.9; ESI MS (m/z): 208.01 (M ); Anal. Calcd for C14H12N : C, 80.74;
58.93; H, 2.78; N, 4.83. Found: C, 58.46; H, 2.34; N, 4.56.
2
◦ −1
Compound 3d: Mp 228–230 C. FTIR (KBr, cm ): 3446, 1576,
H, 5.81; N, 13.45. Found: C, 80.21; H, 5.39; N, 13.08.
◦
−1
−1
1
Compound 1g: Mp 180–182 C. FTIR (KBr, cm ): 3443, 1627,
1537, 1352 cm
; H NMR (400 MHz, DMSO-d6): ı 7.25–7.36 (d,
−1 1
1
459 cm
;
H NMR (400 MHz, DMSO-d6): ı 3.81 (s, 3H), 7.22 (d,
2H), 7.45–7.53 (m, 1H), 7.62–7.71 (d, 2H), 7.48–7.98 (m, 1H),
+
2
H), 7.38–7.47 (m, 2H), 7.48–7.55 (m, 1H), 7.58–7.75 (m, 1H), 7.92
8.28–8.44 (m, 2H); ESI MS (m/z): 256.03 (M ); Anal. Calcd for
1
3
(
d, 2H), 12.93 (s, 1H); C NMR (400 MHz, DMSO-d6): ı 55.6, 114.6
C13H N O S: C, 60.93; H, 3.15; N, 10.93. Found: C, 69.44; H, 2.91;
8
2
2
(
1
2C), 115.3 (2C), 123.0 (2C), 123.2, 128.5 (2C), 138.7 (2C), 152.8,
N, 10.62.
Compound 3e: Mp 224–226 C. FTIR (KBr, cm ): 3536, 3441,
+
◦
−1
60.7; MS (m/z): 224.08 (M ); Anal. Calcd for C14H12N O: C, 74.98;
2
−
1
1
H, 5.39; N, 12.48. Found: C, 74.34; H, 5.06; N, 11.98.
1652, 1448 cm
; H NMR (400 MHz, DMSO-d6): ı 7.10–7.21 (d,
◦
−1
Compound 2a: Mp 100–102 C. FTIR (KBr, cm ): 3456, 1638,
2H), 7.32–7.40 (m, 1H), 7.51–7.60 (d, 2H), 7.46–7.96 (m, 1H),
−1
1
+
1
7
1
1
454 cm
;
H NMR (400 MHz, DMSO-d6): ı 7.23–7.27 (m, 5H),
.51–7.58 (m, 4H); C NMR (400 MHz, DMSO-d6): ı 121.6, 122.3,
8.19–8.35 (m, 2H) 11.3 (s, 1H); ESI MS (m/z): 227.04 (M ); Anal.
1
3
Calcd for C13H NOS: C, 68.70; H, 3.99; N, 6.16. Found: C, 68.36; H,
9
23.5, 124.6 (2C), 125.4, 129.4 (2C), 132.3, 138.5, 150.6, 154.2,
3.62; N, 5.86.
+
◦ −1
Compound 3f: Mp 82–84 C. FTIR (KBr, cm ): 3437, 1648,
62.2;MS (m/z): 195.07 (M ); Anal. Calcd for C13H NO: C, 79.98;
9
−
1 1
H, 4.65; N, 7.16. Found: C, 79.61; H, 3.28; N, 6.84.
1452 cm ; H NMR (400 MHz, DMSO-d6): ı 2.31 (s, 3H), 7.18–7.29
◦
−1
Compound 2b: Mp 146–148 C. FTIR (KBr, cm ): 3451, 1632,
(d, 2H), 7.40–7.48 (m, 1H), 7.54–7.63 (d, 2H), 7.42–7.92 (m, 1H),
−1
1
13
1
458 cm
;
H NMR (400 MHz, DMSO-d6): ı 7.28–7.39 (d, 2H),
8.21–8.37 (m, 2H); C NMR (400 MHz, DMSO-d6): ı 21.3, 121.7,
7
.52–7.60 (m, 1H), 7.65–7.74 (d, 2H), 7.35–7. 86 (m, 1H), 8.11–8.19
123.2, 125.2, 125.5 (2C), 126.4, 132.9, 133.5, 135.1, 138.9 (2C), 154.1,
168.7;ESI MS (m/z): 225.06 (M ); Anal. Calcd for C14H11NS: C, 74.63;
+
+
(m, 2H); MS (m/z): 229.03 (M ); Anal. Calcd for C13H ClNO: C, 67.99;
8
H, 3.51; N, 6.10. Found: C, 67.64; H, 3.18; N, 5.92.
H, 4.92; N, 6.22. Found: C, 69.34; H, 4.58; N, 5.82.
◦
−1
◦ −1
Compound 3g: Mp 118–120 C. FTIR (KBr, cm ): 3432, 1646,
Compound 2c: Mp 142–144 C. FTIR (KBr, cm ): 3456, 1642,
−1
1
−1
1
1
463 cm
;
H NMR (400 MHz, DMSO-d6): ı 7.32–7.43 (d, 2H),
1458 cm ; H NMR (400 MHz, DMSO-d6): ı 3.85 (s, 3H), 7.15–7.26
7
.54–7.62 (m, 1H), 7.63–7.72 (d, 2H), 7.30–7. 81 (m, 1H), 8.09–8.17
(d, 2H), 7.42–7.50 (m, 1H), 7.56–7.65 (d, 2H), 7.48–7.98 (m, 1H),
8.16–8.32 (m, 2H); C NMR (400 MHz, DMSO-d6): ı 54.3, 121.8,
+
13
(m, 2H); ESI MS (m/z): 272.98 (M ); Anal. Calcd for C H BrNO: C,
13
8
5
6.97; H, 2.94; N, 5.11. Found: C, 56.46; H, 2.58; N, 4.78.
123.7, 125.8, 126.7, 127.4 (2C), 130.3 (2C), 135.4, 137.4, 144.4, 154.2,
166.4;ESI MS (m/z): 241.06 (M ); Anal. Calcd for C14H11NOS: C,
69.68; H, 4.59; N, 5.80. Found: C, 69.34; H, 4.18; N, 5.62.
◦
−1
+
Compound 2d: Mp 262–264 C. FTIR (KBr, cm ): 3448, 1587,
−1
1
1
2
8
531, 1354 cm
;
H NMR (400 MHz, DMSO-d6): ı 7.30–7.41 (d,
H), 7.50–7.58 (m, 1H), 7.62–7.71 (d, 2H), 7.33–7. 84 (m, 1H),
+
.10–8.18 (m, 2H); ESI MS (m/z): 240.05 (M ); Anal. Calcd for
C13H N O : C, 65.01; H, 3.36; N, 11.76. Found: C, 64.74; H, 3.08;
2.4. General procedure for the synthesis of quinoxalines
derivatives
8
2
3
N, 11.72.
Compound 2e: Mp 282–284 C. FTIR (KBr, cm ): 3541, 3448,
◦
−1
−
1
1
1
2
8
647, 1454 cm
;
H NMR (400 MHz, DMSO-d6): ı 7.27–7.38 (d,
To a mixture of 1,2-diaminobenzene (1 mmol) and 1,2-
H), 7.42–7.50 (m, 1H), 7.56–7.65 (d, 2H), 7.41–7. 57(m, 1H),
.16–8.32 (m, 2H)), 9.42 (s, 1H); MS (m/z): 211.05 (M ); Anal. Calcd
dicarbonyl compound (1 mmol) in ethanol (10 mL), catalyst
(10 mol%) was added and the solution was refluxed for appro-
priate time. The progress of the reaction was monitored by TLC.
After completion of the reaction, ethyl acetate was added to the
+
for C13H NO : C, 73.91; H, 4.59; N, 6.63. Found: C, 73.64; H, 3.96;
9
2
N, 6.42.